# Sinclair Beats $3B-Backed Altos to the Clinic With First Human Epigenetic Reprogramming Trial

- slug: sinclair-beats-3b-backed-altos-to-the-clinic-with-first-human-epigenetic-reprogramming-trial
- date: 2026-04-04
- category: Biotech & Life Sciences

The FDA cleared the first human trial of partial epigenetic reprogramming. Life Biosciences, a tiny Boston startup co-founded by David Sinclair, beat $3B-backed Altos Labs to the clinic. A 30-year theory of aging is on the line.

---